Beta-Lactams clinical trials
How each study uses beta-Lactams is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the beta-Lactams studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 4
Hoffmann-La Roche (2) · Swiss National Fund for Scientific Research (1) · Mahidol University (1) · Menzies School of Health Research (1) · National Taiwan University Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses beta-Lactams is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal SepticemiaRecruitingPhase 4Mahidol UniversityNCT07240077Written as Beta-lactam monotherapy
- Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus InfectionTerminatedPhase 3Menzies School of Health ResearchNCT02365493Written as Beta-Lactam
- A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial PneumoniaCompletedPhase 2Hoffmann-La RocheNCT00111644Written as beta-lactam
- A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure InfectionsCompletedPhase 2Hoffmann-La RocheNCT00303589Written as beta-lactam
- Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired PneumoniaCompletedPhase 4Swiss National Fund for Scientific ResearchNCT00818610Written as Beta lactam (amoxicillin / clav. acid OR cefuroxime)
- Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill PatientsStatus unknownNot applicableNational Taiwan University HospitalNCT01600768Written as Beta-Lactams
Given beside what is tested · 2 — beta-Lactams is usual care or a partner of the new treatment
- Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPDCompletedPhase 2/3Haiphong University of Medicine and PharmacyNCT04879030Written as Beta-Lactams
- Short Duration Treatment of Non-severe Community Acquired PneumoniaStatus unknownPhase 2Versailles HospitalNCT01963442Written as Beta-Lactams
Codes
What other systems call beta-Lactams · ClinicalTrials.gg INT008850
- MeSH (NLM) D047090beta-LactamsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D047090 | beta-Lactams | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.